Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-10-20
1995-06-13
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 53, 514 54, 514 61, 536 41, 536 53, 536 551, 536 553, 536123, A61K 3170
Patent
active
054242940
ABSTRACT:
N-acyl-N,N'-di-lysogangliosides, N'-acyl-N,N'-di-lysogangliosides and N,N'-diacyl-N,N'-di-lysogangliosides, in which the acyl groups are derived from an organic acid of the aliphatic, aromatic, araliphatic, alicyclic or heterocyclic series and in which at least one of the two acyl groups is not aliphatic, and their preparation are disclosed. Also disclosed is the preparation of the esters, inner esters, amides and hydroxy peracylates of these compounds and salts thereof. These compounds are useful in the treatment of pathologies of the central and peripheral nervous systems.
REFERENCES:
patent: 4476119 (1984-10-01), Della Valle et al.
patent: 4593091 (1986-06-01), Della Valle et al.
patent: 4713374 (1987-12-01), Della Valle et al.
patent: 4716223 (1987-12-01), Della Valle et al.
S. Neuenhofer et al, Biochem. vol. 24 (1985) pp. 525-532.
R. Kannagi et al, Proc. Natl. Acad. Sci. USA, vol. 79 (1982) Biochem. pp. 3470-3474.
W. Sonnino et al, Chemistry and Physics of Lipids, vol. 42 (1986) pp. 3-26.
S. Sonnino et al, Journal of Lipid Research, vol. 26, No. 2 (1985) pp. 248-257.
W. Song et al, Biochemistry, vol. 28 (1989) pp. 4194-4200 Chemical Abstract vol. 110, Formula Index 4100F 1989.
Y. Hirabayashi et al, J. Biochem. vol. 103, No. 1 (1988) pp. 1-4.
P. H. Fishman et al, Journal of Biological Chemistry, vol. 255, No. 16 (1980) pp. 7657-7664.
Biol. Chem. Hoppe Seyler, vol. 367, suppl (1986) p. 241.
G. A. Nores et al, Carbohydrate Research, vol. 179 (1988) pp. 393-410.
N. Hanai et al, Biochemical and Biophysical Research Communications, vol. 147, No. 1 (1987) pp. 127-134.
T. Mosmann, Journal of Immunological Methods, vol. 65 (1983) pp. 55-63.
Engelsen Acta Neurol. Scand. 1986, 74, 337-355.
Olney Ann. Rev. Pharmacol. Toxicol. 1990, 20, 47-71.
Miceli et al. Acta Psychiat. Scand. 1977, 55, 102.
Grillo Eur. Medicophys. 1977, 13, 1.
Ceccharelli et al. Adv. Exp. Med. Biol. 1976, 71, 275.
Gorio et al. Brain Res. 1980, 197, 236.
Leon et al. J. Neurochem. 1981, 37, 350.
Brunngraber et al. "Extraction and Analysis of Materials Containing Lipid Bound Sialic Acid" 1976, 159-186.
Ledeen et al. "Gangliosides of the Nervous System", 187-214.
Klein et al. Eur. J. Biochem. 1987, 167, 417-424.
Sonnino et al. Biochemistry 1989, 28, 77-84.
Kogtev et al. CA110:147995b, 1989 (M. M. Shemyakin Inst. Bioorg. Chem., Moscow USSR).
Sugimoto et al. CA112:56S73n, 1990 (Shionogi & Co. Ltd.).
Electromyogr. Clin. Neurophysiol. 19, 353, (1979).
Minerva Medica, 69, 3277 (1978).
Minerva Stomat. 27, 177, (1978).
Med. Del Larvoro, 68, 296 (1977).
della Valle Francesco
Romeo Aurelio
FIDIA S.p.A.
Fonda Kathleen Kahler
Robinson Douglas W.
LandOfFree
Modified gangliosides and the functional derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified gangliosides and the functional derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified gangliosides and the functional derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1309391